Faisal Hirani is Associate Director, Commercial Strategy and Operations at Regeneron Oncology in Toronto. For nearly a decade, he has designed, built and executed incentive programs for specialty pharma across oncology and rare disease, alongside work in commercial excellence, insights and analytics. He partners with commercial, medical and market access teams on launch readiness and competitive strategy. Previously, he was Commercial Operations Lead at Alexion (AstraZeneca Rare Disease).
